^Zisapel, N (2001). "Melatonin-dopamine interactions: from basic neurochemistry to a clinical setting". Cellular and Molecular Neurobiology21 (6): 605–16. PMID12043836.
^Willis, GL (2008). "Parkinson's disease as a neuroendocrine disorder of circadian function: dopamine-melatonin imbalance and the visual system in the genesis and progression of the degenerative process". Reviews in the Neurosciences19 (4–5): 245–316. PMID19145986.
This page is based on the copyrighted Wikipedia article ( Dopamine antagonist ); it is used under the
GNU Free Documentation License. You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.